for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Bayer can pay more for cancer-busting Algeta

Posted

Nov. 26 - Bayer has offered to pay $2.4 bln for Norway's Algeta, a 27% premium to the stock's last close. But Breakingviews says Algeta’s cancer drug has huge potential and Bayer can afford to pay more.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up